Revvity Inc (RVTY)

Oct 01, 2026

Form 144 REVVITY For: 1 October By Investing.com - Investing.com Canada

Oct 01, 2026

Oct 01, 2026

An officer proposes selling 84 Revvity (NYSE: RVTY) shares valued at $13.1K. - Stock Titan

Oct 01, 2026

Oct 01, 2026

Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance

Oct 01, 2026

Sep 30, 2026

North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.

Sep 30, 2026

Sep 29, 2026

Revvity, Inc. (RVTY) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 29, 2026

Sep 29, 2026

Cloud Fails To Upend Revvity's $4.5M Fee, Contract Win - Law360

Sep 29, 2026

Sep 29, 2026

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 29, 2026

Sep 29, 2026

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now - TradingView

Sep 29, 2026

Sep 29, 2026

Revvity (RVTY): Buy, Sell, or Hold Post Q2 Earnings? - TradingView

Sep 29, 2026

Sep 28, 2026

Revvity, Inc. (RVTY) stock price, news, quote and history - uk.finance.yahoo.com

Sep 28, 2026

Sep 28, 2026

Revvity stock last trades at USD 150.00 on September 28, 2026 - AD HOC NEWS

Sep 28, 2026

Sep 27, 2026

Form 144 REVVITY For: 27 September By Investing.com - Investing.com UK

Sep 27, 2026

Sep 27, 2026

Revvity declares $0.07 quarterly dividend for shareholders - scanx.trade

Sep 27, 2026

Sep 26, 2026

PKI4882935 Bond Profile: Coupon and Redemption - TradingView

Sep 26, 2026

Sep 25, 2026

Revvity options flow shows 156:1 call-to-put ratio ahead of Nov. 2026 expiry - Investing.com

Sep 25, 2026

Sep 25, 2026

Revvity, Inc. (RVTY) latest stock news and headlines – Yahoo Finance - Yahoo Finance Singapore

Sep 25, 2026

Sep 25, 2026

RVTY Launches New Kit in Europe for Newborn Type 1 Diabetes Detection - Yahoo Finance

Sep 25, 2026

Sep 25, 2026

New Products: Qiagen, Helix, Countable Labs, AtlasBio, Revvity, Agilent - GenomeWeb

Sep 25, 2026

Sep 25, 2026

Revvity Q2FY26 Results: Organic growth hits 3%, adjusted EPS $1.41 - scanx.trade

Sep 25, 2026

Sep 25, 2026

Full Transcript: Revvity Q2 2026 Earnings Call - Benzinga

Sep 25, 2026

Sep 25, 2026

Revvity (RVTY) Short Interest & Short Float | Updated Sep 2026 $RVTY - MarketBeat

Sep 25, 2026

Sep 24, 2026

Revvity stock gains 5.2 percent ahead of the open - AD HOC NEWS

Sep 24, 2026

Sep 24, 2026

Revvity Inc (RVTY) Shares Surge 6.0% -- What GF Score of 78 Tells Investors - GuruFocus

Sep 24, 2026

Sep 24, 2026

Here’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years - Benzinga

Sep 24, 2026

Sep 24, 2026

Revvity shares rise as analyst target hike adds to momentum from deal and guidance - Quiver Quantitative

Sep 24, 2026

Sep 24, 2026

Revvity Inc stock hits 52-week high at 149.72 USD By Investing.com - Investing.com India

Sep 24, 2026

Sep 24, 2026

Revvity Inc stock hits 52-week high at 149.72 USD - Investing.com

Sep 24, 2026

Sep 24, 2026

Top Midday Stories: Oracle's Data Center Delay; People Withdraws MGM Offer; Revvity's New Diabetes Test - Yahoo Finance

Sep 24, 2026

Sep 24, 2026

Revvity, Inc. Launches GSP® T1D 3plex Kit For Early Detection Of Type 1 Diabetes - marketscreener.com

Sep 24, 2026

Sep 24, 2026

Revvity Shares Rise on Launch of Child Type 1 Diabetes Screening Test - marketscreener.com

Sep 24, 2026

Sep 24, 2026

RVTY Looks 20.9% Overvalued on GF Value™ as Insider Selling Pers - gurufocus.com

Sep 24, 2026

Sep 24, 2026

Revvity launches type 1 diabetes screening kit in Europe - Investing.com

Sep 24, 2026

Sep 24, 2026

Revvity launches type 1 diabetes screening kit in Europe By Investing.com - Investing.com Canada

Sep 24, 2026

Sep 24, 2026

Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes - Business Wire

Sep 24, 2026

Sep 24, 2026

Leerink Partners Adjusts Revvity Price Target to $160 From $145, Maintains Outperform Rating - marketscreener.com

Sep 24, 2026

Sep 24, 2026

Insider Maxwell Krakowiak Sells 1,631 Shares of Revvity Inc (RVT - GuruFocus

Sep 24, 2026

Sep 24, 2026

Is Revvity Stock Outperforming the Dow? - webull.com

Sep 24, 2026

Sep 23, 2026

Revvity CFO Maxwell Krakowiak sells $235,728 in RVTY stock - Investing.com India

Sep 23, 2026

Sep 23, 2026

Revvity CFO Maxwell Krakowiak sells $235,728 in RVTY stock By Investing.com - Investing.com Australia

Sep 23, 2026

Sep 23, 2026

Form 4 Revvity Inc For: 23 September - Investing.com India

Sep 23, 2026

Sep 23, 2026

After selling 1,631 shares, Revvity (RVTY) CFO holds 14,781 shares - Stock Titan

Sep 23, 2026

Sep 23, 2026

Understanding Momentum Shifts in (RVTY) - news.stocktradersdaily.com

Sep 23, 2026

Sep 22, 2026

Why Revvity (RVTY) Is Getting Attention Today - Yahoo Finance

Sep 22, 2026

Sep 22, 2026

Revvity stock holds near USD 143 after target hike - AD HOC NEWS

Sep 22, 2026

Sep 22, 2026

Revvity stock heads into the open after a Goldman target hike - AD HOC NEWS

Sep 22, 2026

Sep 21, 2026

Revvity Inc. stock gains on Goldman Sachs price target hike - AD HOC NEWS

Sep 21, 2026

Sep 21, 2026

Revvity (NYSE: RVTY) shareholder may sell stock under Rule 144 - Stock Titan

Sep 21, 2026

Sep 21, 2026

Goldman Sachs Adjusts Price Target on Revvity to $140 From $100, Keeps Neutral Rating - Yahoo Finance

Sep 21, 2026

Sep 21, 2026

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Diagnostics Giant with a Cautious Analyst Outlook - DirectorsTalk Interviews

Sep 21, 2026

Sep 20, 2026

Revvity Inc. stock gains on Human Cell Design deal and recent rally - AD HOC NEWS

Sep 20, 2026

Sep 20, 2026

Senior Vice President of Global Operations Tajinder Vohra Sold A Bunch Of Shares In Revvity - simplywall.st

Sep 20, 2026